EGFL7 and hepatocellular carcinoma: MTT assay results indicated that the proliferation of HCC cells in the blank, miR-126 mimic NC, miR-126 inhibitor NC and miR-126 inhibitors + si-EGFL7 groups exhibited no differences (all P > 0.05).